×
Affiliated Organizations
  HN Medical Partners   School of Nursing   HNH Fitness   Villa Marie Claire   Simulation Learning   Haiti Health Promise
Medical Partners Offices
Cardiovascular Specialists University Orthopaedic Pulmonary Specialists Obstetrics & Gynecology North Jersey Heart North Jersey Surgical Surgical Specialistss Primary Care Specialty Assoc. Urologic Specialties Women's Health Care

List of Clinical Studies

  201-541-6312    |      info@holyname.org

Multiple Sclerosis

Study Name Principal Investigator
101MS329– A randomized, controlled, open-label, rater-blinded, phase 3b study of the efficacy, safety, and tolerability of 6-week extended interval dosing of Natalizumab (BG00002) in subjects with relapsing-remitting multiple sclerosis switching from treatment with 4-week Natalizumab standard interval dosing (SID) in relation to continued SID treatment.
Read more.
Mary Ann Picone, MD
MSPT– Feasibility of the multiple sclerosis performance test for assessment of functional performance measures in patients with multiple sclerosis.
Read more.
Mary Ann Picone, MD
WA25046– A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis.
Read more.
Mary Ann Picone, MD
RPC-1063-MS-001 – A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063).
Read more.
Mary Ann Picone, MD